Watchlist Price Alert

VBI Vaccines Inc. (VBIV)

NASDAQ: VBIV · Real-Time Price · USD

0.07

-0.06 (-47.33%)

At close: Aug 07, 2024, 8:00 PM

VBI Vaccines Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	8.68M	1.08M	631K	1.06M	2.22M	3.35M	865K	548K
Cost of Revenue	14.5M	11.28M	10.77M	9.17M	7.9M	4.51M	5.19M	3.67M
Gross Profit	-5.82M	-10.19M	-10.14M	-8.11M	-5.68M	-1.15M	-4.33M	-3.12M
Operating Income	-55.31M	-81.82M	-68.03M	-43.62M	-52.4M	-60.41M	-37.28M	-24.85M
Interest Income	1.66M	1.39M	372K	613K	835K	622K	n/a	n/a
Pretax Income	-92.84M	-113.3M	-69.75M	-46.23M	-54.81M	-63.6M	-39.43M	-24.98M
Net Income	-92.84M	-140.95M	-72.65M	-47.29M	-55.8M	-63.6M	-38.99M	-23.2M
Selling & General & Admin	40.15M	56.12M	38.34M	20.65M	14.09M	20.79M	12.03M	11.76M
Research & Development	9.34M	15.51M	19.56M	14.86M	26.33M	38.47M	20.92M	9.97M
Other Expenses	24.6M	n/a	n/a	20.65M	20.38M	20.79M	12.03M	11.76M
Operating Expenses	49.5M	71.63M	57.89M	35.51M	40.42M	59.25M	32.95M	21.73M
Interest Expense	8.06M	4.01M	4.73M	2.71M	2.2M	3.25M	2.88M	324K
Selling & Marketing Expenses	-1.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	63.99M	82.9M	68.66M	44.68M	48.33M	63.76M	38.15M	25.4M
Income Tax Expense	1.82M	27.65M	2.9M	1.06M	992K	560K	-431K	-1.78M
Shares Outstanding (Basic)	15.57M	8.61M	8.5M	7.28M	3.98M	2.19M	1.47M	1M
Shares Outstanding (Diluted)	15.57M	8.61M	8.5M	7.28M	3.98M	2.19M	1.47M	1M
EPS (Basic)	-5.96	-16.37	-8.55	-6.5	-14.02	-29.06	-26.49	-23.17
EPS (Diluted)	-5.96	-16.37	-8.55	-6.5	-14.02	-29.06	-26.49	-23.17
EBITDA	-53.32M	-106.02M	-62.81M	-41.26M	-52.4M	-59.59M	-36.55M	-24.24M
EBIT	-84.77M	-108.08M	-64.65M	-42.91M	-52.62M	-60.35M	-36.54M	-24.66M
Depreciation & Amortization	1.99M	2.06M	1.83M	1.65M	1.2M	542K	730K	606K